Hinge Health just broke open the digital health IPO market. Here's who's getting rich.

Hinge Health, a virtual physical therapy startup, went public with its shares jumping 23% to over $39 on Thursday from its IPO price of $32, valuing the company at approximately $3 billion. The IPO raised $437 million, marking a significant moment for the digital health IPO market after a period of limited activity; however, the IPO valuation of $2.6 billion represents a 52% markdown from its $6.2 billion private valuation in 2021. Major investors like Insight Partners and Tiger Global hold substantial stakes, with Insight Partners' remaining stake valued at $433 million after selling a portion of its shares in the IPO.

Analysis

Hinge Health's initial public offering, which saw its shares surge 23% on debut from $32 to $39.25 and achieve a market capitalization of approximately $3 billion, represents a notable development for the digital health industry, which has seen limited IPO activity in the last three years compared to 23 in 2021. The IPO raised $437 million, split between $273 million for the company and $164 million for selling shareholders. However, this public debut came at an IPO valuation of $2.6 billion, a significant 52% markdown from its $6.2 billion private valuation secured in a 2021 Series E round co-led by Tiger Global and Coatue Management, underscoring a valuation reset from the 2021 venture peak. While several venture investors like Insight Partners (stake now $433M after selling 1.25M shares) and Atomico (stake $309M after selling approximately 1.5M shares) capitalized on the IPO for partial liquidity, key insiders including CEO Daniel Perez (stake $414M) and co-founder Gabriel Mecklenburg (stake $158M) retained their full holdings. This IPO, initially delayed by market volatility, serves as a positive, albeit cautious, signal for the digital health market's public exit potential.

Key Decisions for Investors

• Investors should observe Hinge Health's post-IPO stock performance and subsequent financial reporting closely, as its success could reinvigorate investor interest in the digital health IPO pipeline, but remain mindful of the substantial valuation reset from its peak private funding round.
• The retention of shares by key executives, including the CEO and co-founder, signals internal confidence, a factor to weigh against the partial exits by several venture capital backers who realized liquidity.
• Consider the Hinge Health IPO as a case study in current market dynamics, where strong initial public demand can coexist with significant discounts to prior high private valuations, particularly for companies heavily funded during the 2021 peak.
• For those evaluating investments in similar late-stage private digital health companies or upcoming IPOs in the sector, the Hinge Health pricing and investor actions provide a crucial benchmark for realistic public market valuation expectations and potential selling pressure from early investors.